08/2022

• Portfolio News

  DeepWay Completes Series A Round of 460m RMB Led by Qiming Venture Partners

• Portfolio News

  Several Key Research Supported by Amoy Diagnostics were Presented at WCLC 2022

• Portfolio News

  ZhenGe Biotech Announced the Completion of 100m RMB Series C+ Funding

• Portfolio News

  CanSinoBIO's Convidecia Air? Receives Clinical Trial Approval in Malaysia

• Portfolio News

  Belief BioMed's BBM-H901 Injection was Granted Orphan Drug Designation by FDA

• Qiming News

  Qiming Monthly Newsletter (July 2022)

• Qiming News

  Qiming Insights | Exclusive interview with Duane Kuang on investment prospects in China, entrepreneurship and Web3.0

• Portfolio News

  Asieris' Multinational Phase III Clinical Trial Has Completed Enrollment

• Portfolio News

  Insta360 Launches AI-powered 4K Camera Link to Redefine Remote Work

• Portfolio News

  GluBio Completes Series A+ Round of $22m to Advance Development of Novel TPD Drugs

• Portfolio News

  OriCell Therapeutics Raises Over $120m in Series B Financing

07/2022

• Portfolio News

  Qiming's Portfolio Company InventisBio Lists on STAR Market

• Portfolio News

  Chatail Completes Series B Financing Round Led by Qiming Venture Partners

• Qiming News

  Qiming Venture Partners Announces Closing of US$3.2b Funds

06/2022

• Portfolio News

  OriCell Reports OriCAR-017 Phase I POLARIS study Data in Oral Presentation at American Society of Clinical Oncology (ASCO) Annual Meeting 2022

05/2022

• Portfolio News

  WeRide received strategic investment from Bosch to jointly develop the auto grade and mass production of advanced driving solution in China

• Portfolio News

  Insilico Medicine Announced Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment

• Portfolio News

  CanSinoBIO's COVID-19 Vaccine Convidecia? Receives WHO Emergency Use Listing

• Portfolio News

  Clinical trial results of Belief BioMed's hemophilia B gene therapy drug candidate BBM-H901 published in The Lancet Haematology

• Portfolio News

  LaNova Medicines and Turning Point Therapeutics Enter into Licensing Agreement for LM-302 Antibody Drug Conjugate Program

• Portfolio News

  WeRide Reached Strategic Cooperation with Hesai, Leading the Application of Hybrid Solid-State Lidar on L4 Autonomous Vehicle

04/2022

• Portfolio News

  WeRide announces self-driving Robosweepers roll off the assembly line

• Portfolio News

  VenusP-Valve? obtains CE marking under MDR and debuts in Europe as China's first valve product

• Qiming News

  Qiming’s Nisa Leung, Duane Kuang Named on 2022 Forbes Midas List

03/2022

• Portfolio News

  Qiming’s Portfolio Company Rendu Biotechnology Lists on STAR Market

• Portfolio News

  Qiming’s Portfolio Company Arrail Group Lists on Main Board of HKEX

• Qiming News

  Qiming Monthly Newsletter (February 2022)

• Qiming News

  Retailers, Logistics Companies to Introduce Affordable Rapid Test Kits in Hong Kong

• Qiming News

  Qiming Venture Partners Welcomes David Chu as IR Partner

02/2022

• Portfolio News

  Convidecia Approved as Heterologous Booster in China

• Portfolio News

  Pluslife Biotech – A Greater Bay Area Company Launches First Handheld Covid-19 Nucleic Acid Test

• Qiming News

  Qiming Monthly Newsletter (November 2021 - January 2022)

01/2022

• Qiming News

  Qiming Venture Partners Announces Annual Promotions

• Portfolio News

  Qiming’s Portfolio Company Asieris Pharmaceuticals Lands on STAR Market

• Qiming News

  Shiyu Wang Rejoins Qiming Venture Partners as Partner Co-Leads TMT Team

12/2021

• Qiming News

  Qiming Venture Partners to Hold 13th CEO Summit This Week

11/2021

• Qiming News

  Nisa Leung on SCMP: How Hong Kong plays a central role in the biotech investment boom

• Qiming News

  Qiming Participates in $156m round in CRO Firm Tripod

10/2021

• Portfolio News

  Beijing’ Covid Booster Campaign Includes Cansino’s Vaccine: Bloomberg

• Portfolio News

  ShouTi Secures $100 Million Series B Financing, Qiming Participated

• Qiming News

  Qiming Monthly Newsletter October

• Qiming News

  How China turned the tables on biopharma's global dealmaking: Endpoints News

• Portfolio News

  WeRide unveils China's first Level 4 self-driving cargo van

• Portfolio News

  Geneseeq and Zai Lab Announce Strategic Collaboration to Advance Cancer Drug R&D

• Portfolio News

  Qiming’s Portfolio Company Microtech Medical Lists on Main Board of HKEx

• Portfolio News

  Qiming’s Portfolio Company Abbisko Lists on Main Board of HKEx

09/2021

• Portfolio News

  Qiming’s Portfolio Company Broncus Lists on Main Board of HKEx

• Portfolio News

  Chinese driverless car firm WeRide launches ‘Robovan’ for autonomous deliveries: CNBC

• Portfolio News

  Indonesia approves J&J, Cansino COVID-19 vaccines for emergency use: Reuters

• Portfolio News

  CanSino booster shot increases antibodies 78-fold

• Portfolio News

  Alamar Biosciences Completes $80M Series B Fundraising to Bring Unprecedented Performance to the Proteomics Market

• Qiming News

  Qiming's Nisa Leung on Investments in China's Biotech Industry: Bloomberg

• Qiming News

  Qiming Venture Partners Monthly Newsletter | August

08/2021

• Portfolio News

  ‘AI doctor’developer Zuoshouyisheng raises USD 15.5 million in Series B: KrAsia

• Portfolio News

  Blockchain Startup InfStones Raises $10M in Series A Funding Round: CoinDesk

• Portfolio News

  AmoyDx? Pan Lung Cancer PCR Panel Receives MHLW Approval as Companion Diagnostic for TEPMETKO? (tepotinib)

• Portfolio News

  China's mRNA vaccine technology firm Abogen raises over $700 mln: Reuters

• Portfolio News

  InferVision AI Assists the European Commission Monitoring COVID-19 Variants

• Portfolio News

  InferVision Completes Series D2 Financing Round

• Portfolio News

  Qiming’s Portfolio Company Sino Biological Lists on Shenzhen’s ChiNext Market